newsfilter
← Latest News
GlobeNewswire·

Galecto Reports Second Quarter 2025 Operating and Financial Results

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and